+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Regulatory Affairs Market by Services (Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting), Indication (Cardiology, Immunology, Neurology), Stage, Category, Service Provider, Company Size, End-Use - Forecast 2024-2030- Product Image
Global Regulatory Affairs Market by Services (Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting), Indication (Cardiology, Immunology, Neurology), Stage, Category, Service Provider, Company Size, End-Use - Forecast 2024-2030- Product Image
Sale

Global Regulatory Affairs Market by Services (Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting), Indication (Cardiology, Immunology, Neurology), Stage, Category, Service Provider, Company Size, End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666622
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Regulatory Affairs Market size was estimated at USD 15.63 billion in 2023, USD 17.22 billion in 2024, and is expected to grow at a CAGR of 10.63% to reach USD 31.71 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Regulatory Affairs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Regulatory Affairs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Regulatory Affairs Market, highlighting leading vendors and their innovative profiles. These include Asphalion, S.L., Cambridge Regulatory Services, Charles River Laboratories, Inc., Clinilabs Inc., Educo Life Sciences Ltd, Exalon GmbH, Genpact Ltd., ICON PLC, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Inc., NDA Group AB, Pharmalex GMBH, Qvigilance, and WuXi AppTec Co. Ltd.

Market Segmentation & Coverage

This research report categorizes the Regulatory Affairs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Legal Representation
    • Product Registration & Clinical Trial Applications
    • Regulatory Consulting
    • Regulatory Writing & Publishing
  • Indication
    • Cardiology
    • Immunology
    • Neurology
    • Oncology
  • Stage
    • Clinical Studies
    • Preclinical
  • Category
    • Biologics
      • Biosimilars
      • Biotech
    • Drugs
      • Generics
      • Innovator
    • Medical Devices
      • Diagnostics
      • Therapeutics
  • Service Provider
    • In-House
    • Outsourced
  • Company Size
    • Large
    • Medium
    • Small
  • End-Use
    • Biotechnology Companies
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Regulatory Affairs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Regulatory Affairs Market?
  3. What are the technology trends and regulatory frameworks in the Regulatory Affairs Market?
  4. What is the market share of the leading vendors in the Regulatory Affairs Market?
  5. Which modes and strategic moves are suitable for entering the Regulatory Affairs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Regulatory Affairs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant growth in drug discovery and development worldwide
5.1.1.2. Changing governmental regulatory landscapes for healthcare sector
5.1.1.3. Rising prevalence of rare disorders and emergence of novel infectious diseases
5.1.2. Restraints
5.1.2.1. High cost of delivering regulatory services
5.1.3. Opportunities
5.1.3.1. Massive investments by the key market players for development of healthcare equipment
5.1.3.2. Increasing consumer preference for biologics and generic drugs
5.1.4. Challenges
5.1.4.1. Stringent governmental policies and regulations associated with regulatory affairs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Regulatory Affairs Market, by Services
6.1. Introduction
6.2. Legal Representation
6.3. Product Registration & Clinical Trial Applications
6.4. Regulatory Consulting
6.5. Regulatory Writing & Publishing
7. Regulatory Affairs Market, by Indication
7.1. Introduction
7.2. Cardiology
7.3. Immunology
7.4. Neurology
7.5. Oncology
8. Regulatory Affairs Market, by Stage
8.1. Introduction
8.2. Clinical Studies
8.3. Preclinical
9. Regulatory Affairs Market, by Category
9.1. Introduction
9.2. Biologics
9.3.1. Biosimilars
9.3.2. Biotech
9.3. Drugs
9.4.1. Generics
9.4.2. Innovator
9.4. Medical Devices
9.5.1. Diagnostics
9.5.2. Therapeutics
10. Regulatory Affairs Market, by Service Provider
10.1. Introduction
10.2. In-House
10.3. Outsourced
11. Regulatory Affairs Market, by Company Size
11.1. Introduction
11.2. Large
11.3. Medium
11.4. Small
12. Regulatory Affairs Market, by End-Use
12.1. Introduction
12.2. Biotechnology Companies
12.3. Medical Device Companies
12.4. Pharmaceutical Companies
13. Americas Regulatory Affairs Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Regulatory Affairs Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Regulatory Affairs Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.2. Market Share Analysis, By Key Player
16.3. Competitive Scenario Analysis, By Key Player
17. Competitive Portfolio
17.1. Key Company Profiles
17.1.1. Asphalion, S.L.
17.1.2. Cambridge Regulatory Services
17.1.3. Charles River Laboratories, Inc.
17.1.4. Clinilabs Inc.
17.1.5. Educo Life Sciences Ltd
17.1.6. Exalon GmbH
17.1.7. Genpact Ltd.
17.1.8. ICON PLC
17.1.9. IQVIA Holdings Inc.
17.1.10. Laboratory Corporation of America Holdings
17.1.11. Medpace Inc.
17.1.12. NDA Group AB
17.1.13. Pharmalex GMBH
17.1.14. Qvigilance
17.1.15. WuXi AppTec Co. Ltd.
17.2. Key Product Portfolio
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. REGULATORY AFFAIRS MARKET RESEARCH PROCESS
FIGURE 2. REGULATORY AFFAIRS MARKET SIZE, 2023 VS 2030
FIGURE 3. REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. REGULATORY AFFAIRS MARKET DYNAMICS
FIGURE 7. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2023 VS 2030 (%)
FIGURE 12. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
FIGURE 14. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2023 VS 2030 (%)
FIGURE 16. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2023 VS 2030 (%)
FIGURE 18. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 20. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 24. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 29. REGULATORY AFFAIRS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 30. REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. REGULATORY AFFAIRS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 6. REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 11. REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 16. REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 19. REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 21. REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 25. REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 29. REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 32. REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 35. REGULATORY AFFAIRS MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. REGULATORY AFFAIRS MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. CANADA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 76. CANADA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 77. CANADA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 78. CANADA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 79. CANADA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 80. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 81. CANADA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 82. CANADA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 84. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 87. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 90. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. CHINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. CHINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 128. CHINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 129. CHINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 130. CHINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 131. CHINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 132. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 133. CHINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 134. CHINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. INDIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. INDIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 138. INDIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 139. INDIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 140. INDIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. INDIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 142. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 143. INDIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 144. INDIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 156. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 158. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 159. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 160. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 161. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 162. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 163. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 215. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 216. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 218. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 219. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 220. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 221. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 222. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 223. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 224. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 246. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 247. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 248. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 249. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 250. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 252. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 253. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 254. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 256. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 257. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 258. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 259. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 260. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 261. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 262. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 263. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 264. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 266. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 267. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 269. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 270. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 271. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 272. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 273. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 274. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 276. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 277. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 278. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 279. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 280. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 282. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 283. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 284. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 285. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 286. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 287. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 288. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 289. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 290. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 291. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 292. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 293. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 294. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 295. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 306. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 307. ITALY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. ITALY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 309. ITALY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 310. ITALY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 311. ITALY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 312. ITALY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 313. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 314. ITALY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 315. ITALY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 326. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 336. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 337. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 338. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 339. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 340. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 341. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 342. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 343. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 344. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 345. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 346. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 347. POLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 348. POLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 349. POLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 350. POLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 351. POLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 352. POLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 353. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 354. POLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 355. POLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 356. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 357. QATAR REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 358. QATAR REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 359. QATAR REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 360. QATAR REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 361. QATAR REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 362. QATAR REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 363. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER,

Companies Mentioned

  • Asphalion, S.L.
  • Cambridge Regulatory Services
  • Charles River Laboratories, Inc.
  • Clinilabs Inc.
  • Educo Life Sciences Ltd
  • Exalon GmbH
  • Genpact Ltd.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Medpace Inc.
  • NDA Group AB
  • Pharmalex GMBH
  • Qvigilance
  • WuXi AppTec Co. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 17.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 31.71 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Regulatory Affairs Outsourcing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Regulatory Affairs Outsourcing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 77 Pages
  • Global
From
Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Services (Consulting, Auditing & Assessment), By End-use (Pharma, Biotech), By Region, And Segment Forecasts, 2023-2030 - Product Image

Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Services (Consulting, Auditing & Assessment), By End-use (Pharma, Biotech), By Region, And Segment Forecasts, 2023-2030

  • Report
  • 133 Pages
  • Global
From
Global Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Forecast 2024-2030 - Product Image

Global Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Biotechnology & Pharmaceutical Services Outsourcing Market by Services (Auditing & Assessment, Consulting, Product Design & Development), End-User (Biotech Companies, Pharmaceutical Companies) - Forecast 2024-2030 - Product Image

Global Biotechnology & Pharmaceutical Services Outsourcing Market by Services (Auditing & Assessment, Consulting, Product Design & Development), End-User (Biotech Companies, Pharmaceutical Companies) - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 173 Pages
  • Global
From

About the Regulatory Affairs Market

Regulatory Affairs in the biotechnology industry is the process of obtaining and maintaining approval from regulatory authorities for the development, manufacture, and marketing of biotechnology products. This includes the submission of applications, such as Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Biologics License Applications (BLAs). Regulatory Affairs professionals are responsible for ensuring that biotechnology products comply with applicable laws and regulations. Regulatory Affairs professionals must have a thorough understanding of the regulatory environment and the ability to interpret and apply regulations to the development and marketing of biotechnology products. They must also be able to effectively communicate with regulatory authorities and other stakeholders. Companies in the Regulatory Affairs market in the biotechnology industry include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.